Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amt-116 car-t cells (1 trial)
amt-253 car-t cells (1 trial)
cd19 car-t cells (5 trials)
cyclophosphamide (cytoxan) (4 trials)
fludarabine (fludara) (4 trials)
im19 car-t cells (4 trials)
cd123 car-t cells (1 trial)
cisplatin (platinol) (1 trial)
decitabine (dacogen) (1 trial)
dexamethasone (1 trial)
gemcitabine (gemzar) (1 trial)
gpc3 car-t cell (1 trial)
im21 car-t cell (3 trials)
im73 car-t cells (1 trial)
im83 car-t cells (1 trial)
im92 car-t cells (1 trial)
im96 car-t cells (1 trial)
rituximab (rituxan) (1 trial)
Lymphoma (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Multiple Myeloma (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Trials (20 total)
Trial APIs (18 total)